KR880007059A - 염화리소짐 및 글리치르히진산 디칼륨 함유 수용액 제제 - Google Patents

염화리소짐 및 글리치르히진산 디칼륨 함유 수용액 제제 Download PDF

Info

Publication number
KR880007059A
KR880007059A KR870013602A KR870013602A KR880007059A KR 880007059 A KR880007059 A KR 880007059A KR 870013602 A KR870013602 A KR 870013602A KR 870013602 A KR870013602 A KR 870013602A KR 880007059 A KR880007059 A KR 880007059A
Authority
KR
South Korea
Prior art keywords
potassium
sodium
chloride
aqueous solution
salt
Prior art date
Application number
KR870013602A
Other languages
English (en)
Other versions
KR910005885B1 (ko
Inventor
요시오 고구레
Original Assignee
나이또오 유우지
에자이 가부시끼 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 나이또오 유우지, 에자이 가부시끼 가이샤 filed Critical 나이또오 유우지
Publication of KR880007059A publication Critical patent/KR880007059A/ko
Application granted granted Critical
Publication of KR910005885B1 publication Critical patent/KR910005885B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)

Abstract

내용 없음.

Description

염화리소짐 및 글리치르히진산 디칼륨 함유 수용액 제제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 염화 리소짐과, 글리치트히진산 디칼륨, 염화나트륨, 염화칼륨, 염화칼슘, 염화마그네슘, 인산나트륨, 인산칼륨, 시트르산나트륨, 시트르산칼륨, 탄산나트륨 및 탄산칼륨으로 구성된 군에서 선택된 적어도 일원과로 되어 있으며 pH5 내지 9를 갖는 것을 특징으로 하는 수용액 제제.
  2. 제1항에 있어서, 0.1 내지 0.5중량%의 염화리소짐과 0.05 내지 0.25중량%의 글리치트히진산 디칼륨을 포함하는 것을 특징으로 하는 수용액 제제.
  3. 제1항에 있어서, 인산염(나트륨염 또는 칼륨염)이 1수소염 또는 2수소염이고, 시트르산염(나트륨염 또는 칼륨염)이 1수소염 또는 2수소염이고, 탄산염(나트륨염 또는 칼륨염)이 1수소염인 것을 특징으로 하는 수용액 제제.
  4. 제1항에 있어서, pH7.0 내지 7.5를 갖는 것을 특징으로 하는 수용액 제제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019870013602A 1986-12-19 1987-12-01 염화리소짐 및 글리치르히진산 디칼륨 함유 수용액제제 KR910005885B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP61303163A JPH085800B2 (ja) 1986-12-19 1986-12-19 塩化リゾチ−ム及びグリチルリチン酸ジカリウム含有水溶液製剤
JP61-303163 1986-12-19
JP86-303163 1986-12-19

Publications (2)

Publication Number Publication Date
KR880007059A true KR880007059A (ko) 1988-08-26
KR910005885B1 KR910005885B1 (ko) 1991-08-06

Family

ID=17917640

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870013602A KR910005885B1 (ko) 1986-12-19 1987-12-01 염화리소짐 및 글리치르히진산 디칼륨 함유 수용액제제

Country Status (10)

Country Link
US (1) US4961927A (ko)
EP (1) EP0275457B1 (ko)
JP (1) JPH085800B2 (ko)
KR (1) KR910005885B1 (ko)
AT (1) ATE73670T1 (ko)
DE (1) DE3777611D1 (ko)
ES (1) ES2036566T3 (ko)
GR (1) GR3004119T3 (ko)
PH (1) PH24628A (ko)
PT (1) PT86400B (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0327756B1 (en) * 1987-11-13 1994-01-26 Smithkline Beecham Farmaceutici S.p.A. Pharmaceutical compositions comprising a calcitonin and a glycyrrhizinate as absorption enhancer
JP2700465B2 (ja) * 1988-05-09 1998-01-21 関西酵素株式会社 塩化リゾチーム配合トイレタリー製品
IT8920486A0 (it) * 1989-05-12 1989-05-12 Isf Spa Composizioni farmaceutiche.
JPH06199648A (ja) * 1993-01-08 1994-07-19 Kao Corp 可溶化型化粧料
US5482710A (en) * 1993-07-30 1996-01-09 Chesebrough-Pond'usa Co., Division Of Conopco, Inc. Cosmetic composition for treatment of pimples and redness
CA2232855C (en) * 1997-04-10 2007-10-09 Roche Consumer Health (Worldwide) Sa Pharmaceutical formulation
IT1291366B1 (it) * 1997-05-14 1999-01-07 Angelini Ricerche Spa Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale
US6649176B1 (en) 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water
US6630175B1 (en) * 2000-06-29 2003-10-07 Johnson & Johnson Consumer Companies, Inc. Method of reducing eye irritation
US6372791B1 (en) 2000-06-29 2002-04-16 Johnson & Johnson Consumer Companies, Inc. Method of promoting skin cell metabolism
US6432424B1 (en) 2000-06-29 2002-08-13 Johnson & Johnson Consumer Companies, Inc. Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid
US7678389B1 (en) * 2004-06-16 2010-03-16 Scott Cordray Treatment of optic and otic inflammation
WO2007008618A2 (en) * 2005-07-13 2007-01-18 University Of South Carolina Sterilization using high-pressure carbon dioxide
US20070264362A1 (en) * 2006-05-11 2007-11-15 Nina Yoshpe Method and composition for treating ear inflammation caused by dry ear
EP2134355A4 (en) * 2007-03-02 2012-01-11 Saint Simeon Lda NOVEL OPHTHALMIC COMPOSITIONS CONTAINING RECOMBINANT HUMAN LYSOZYME AND USE THEREOF FOR TREATING DISORDERS THEREOF AND SOLUTION FOR CONTACT LENSES
JP5274826B2 (ja) * 2007-12-12 2013-08-28 サンスター株式会社 口腔用組成物
IT1401153B1 (it) * 2010-07-28 2013-07-12 Neova Technologies B V Formulazioni di lisozima gelificato
US8758836B2 (en) 2011-09-09 2014-06-24 Nina S. YOSHPE Method and formulation for treating dry ear inflammation with cortisone
WO2017209721A1 (en) 2016-06-02 2017-12-07 Alemdar Eda A drug derived from enzymes present in the human saliva for use in preventing corneal clouding or cataract formation
CN109718246A (zh) * 2019-02-19 2019-05-07 刘宝林 一种鼻腔清洗液

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB843135A (en) * 1957-07-16 1960-08-04 Biorex Laboratories Ltd Glycyrrhetinic acid salts
US3419471A (en) * 1965-04-19 1968-12-31 Eisai Co Ltd Preparation of albumin-free lysozyme
FR2037000A1 (en) * 1969-04-30 1970-12-31 Pluripharm Non allergic lysozyme chlorhydrate prepn
JPS49310A (ko) * 1972-04-14 1974-01-05
JPS56110609A (en) * 1980-02-06 1981-09-01 Lion Corp Composition for oral cavity
JPS5746922A (en) * 1980-09-05 1982-03-17 Ss Pharmaceut Co Ltd Stable aqueous lysozyme solution
GB2122893B (en) * 1982-06-30 1985-06-26 Biorex Laboratories Ltd Glycyrrhetinic acid compositions
AU553789B2 (en) * 1982-06-30 1986-07-24 Biorex Laboratories Ltd. Glycyrrhetinic acid derivatives in cream compositions

Also Published As

Publication number Publication date
JPH085800B2 (ja) 1996-01-24
US4961927A (en) 1990-10-09
EP0275457B1 (en) 1992-03-18
KR910005885B1 (ko) 1991-08-06
PT86400A (en) 1988-01-01
EP0275457A2 (en) 1988-07-27
DE3777611D1 (de) 1992-04-23
JPS63156728A (ja) 1988-06-29
ATE73670T1 (de) 1992-04-15
GR3004119T3 (ko) 1993-03-31
PH24628A (en) 1990-08-17
EP0275457A3 (en) 1988-09-07
ES2036566T3 (es) 1993-06-01
PT86400B (pt) 1990-11-20

Similar Documents

Publication Publication Date Title
KR880007059A (ko) 염화리소짐 및 글리치르히진산 디칼륨 함유 수용액 제제
KR850006135A (ko) 안 과 액 제
BR8601404A (pt) Composicao de alvejamento aquosa,estavel,espessada,de baixo ph
SE8303696D0 (sv) Farmakologiska kompositioner
BR9001411A (pt) Composicao aquosa detergente liquida
KR900015612A (ko) 글루타르알데하이드와 1,2-벤즈이소티아졸린-3-온의 수성 농축 용액
KR850004266A (ko) 반코 마이신의 분리방법
AU6746087A (en) Dialdehyde containing compositions
KR920008058A (ko) 고체 락툴로스
CA1272726C (en) 2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines
KR860006542A (ko) 안정화된 효소결합체 조성물
NO942983L (no) Farmasöytiske sammensetninger
DE3665320D1 (en) Stabilization of peroxidase activity in solution
KR840002901A (ko) 세라펩타제를 안정화 세라펩타제를 안정화 시키는 방법
KR860003791A (ko) 단백질 가수 분해물의 점도 조절방법
ES8603434A1 (es) Un procedimiento para la produccion del 1, 2, 4-triazolilpropanol
KR870011238A (ko) 세제조성물
KR840004116A (ko) 7β-(2D-2-아미노-2-카르복시-에틸티오아세트아미드)-7α-메톡시-3-(1-메틸-1H-테트라졸-5-일)-티오메틸-3-세펨-4-카르본산나트륨염 7수화물의 제조방법
KR870008789A (ko) 탄산칼슘 표면 처리방법
AU1491583A (en) Optically active imidazolylpropanols
KR890003626A (ko) 인산부산석고의 중화방법
KR880001678A (ko) 항균제
KR840001989A (ko) 습식 히이터
MY102537A (en) Aqueous polysaccharide compositions
KR910012071A (ko) 폴리에틸렌 테레프탈레이트 수지조성물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19960719

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee